ScreenPoint Medical

ScreenPoint helps radiologists detect breast cancer confidently and faster. We develop and market image analysis and machine learning applications and services to improve early detection of breast cancer. Our flagship product - Transpara - has been evaluated in over 35+ peer-reviewed publications and has demonstrated consistent results, regardless of patient age, breast density, or ethnicity. Transpara uses the latest developments in machine learning such as Deep Learning and is trained with very large well curated databases of screening mammograms. Research and development at ScreenPoint is aimed at improving performance to the level of expert radiologists and beyond

Computer-aided detection (cad),medical imaging,decision support,deep learning,breast cancer,mammography,and screening

Screenpoint medical operates in the Medical equipment manufacturing industry.

Screenpoint medical's revenue is 11m - 100m

Screenpoint medical has 51 - 200 employees.